08/07/2025 9:16 AM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G/A | |
08/07/2025 7:37 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/07/2025 7:40 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/25/2025 4:22 PM | Bitterman Kevin (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2025 3:25 PM | Atlas Venture Fund X, L.P. (Reporting) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/24/2025 3:27 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2025 3:51 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/18/2025 3:31 PM | Atlas Venture Fund X, L.P. (Reporting) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2025 3:33 PM | Atlas Venture Opportunity Fund I, L.P. (Reporting) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2025 3:20 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Franchi Jean M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/16/2025 4:50 PM | AHMED NADIM (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
Get the Latest News and Ratings for GMTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Gemini Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
|
07/16/2025 4:56 PM | AHMED NADIM (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/14/2025 8:36 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/14/2025 7:37 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/11/2025 3:48 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/10/2025 3:34 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Franchi Jean M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/08/2025 7:19 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/03/2025 12:30 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Quisel John D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/01/2025 3:50 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/18/2025 4:18 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/16/2025 3:22 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Franchi Jean M. (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/13/2025 4:29 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Ratcliffe Liam (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:32 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:05 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/13/2025 4:10 PM | Ashiya Mona (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:14 PM | Bitterman Kevin (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:18 PM | Chin Mark (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:23 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) GEMAYEL GEORGES (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/13/2025 4:25 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Nicholson Donald William (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/09/2025 7:49 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/06/2025 3:25 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Savage William Jacob (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/22/2025 5:31 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/15/2025 3:40 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Paradigm Biocapital Advisors LP (Filed by)
| Form SCHEDULE 13G/A | |
05/12/2025 9:44 AM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G | |
05/07/2025 7:37 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/07/2025 7:05 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/06/2025 7:53 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/02/2025 3:22 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Savage William Jacob (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/24/2025 3:44 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form DEF 14A | |
04/24/2025 3:47 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form DEFA14A | |
04/08/2025 7:22 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
FOUR TRILLION DOLLARS! (Ad) Nvidia just became the first company in history to hit a $4 trillion valuation—surpassing Apple and Microsoft. But one controversial analyst, known for predicting the collapses of Fannie Mae, GM, and others, is issuing a serious warning.
He believes Nvidia’s rise has masked a dangerous flaw—and that the stock could fall 50% or more from current levels. Click here to watch his urgent Nvidia exposé before the hype turns to panic. |
03/26/2025 6:00 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/26/2025 6:08 PM | Ashiya Mona (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 7:00 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/21/2025 7:03 PM | Ashiya Mona (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 8:34 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) ORBIMED ADVISORS LLC (Reporting) OrbiMed Capital GP VI LLC (Reporting) OrbiMed Capital GP VIII LLC (Reporting) OrbiMed Genesis GP LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 8:36 PM | Ashiya Mona (Reporting) Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/12/2025 6:57 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) ORBIMED ADVISORS LLC (Filed by)
| Form SCHEDULE 13D/A | |
03/10/2025 5:46 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 5:44 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/10/2025 5:45 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) ORBIMED ADVISORS LLC (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2025 7:56 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/27/2025 7:17 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/27/2025 7:11 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/20/2025 6:27 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 6:29 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 6:31 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Yu Jonathan Yen-Wen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 6:33 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 6:36 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Khara Rahul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2025 6:38 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Stephenson Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2025 6:50 AM | Bain Capital Life Sciences Opportunities III, LP (Filed by) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form SCHEDULE 13G/A | |
02/12/2025 5:43 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Khara Rahul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:48 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Stephenson Pamela (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:33 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:35 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:38 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Franchi Jean M. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 5:40 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Yu Jonathan Yen-Wen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2025 8:08 AM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) FMR LLC (Filed by)
| Form SCHEDULE 13G | |
02/10/2025 9:25 AM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SCHEDULE 13G/A | |
02/03/2025 3:28 PM | Atlas Venture Fund X, L.P. (Reporting) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
01/23/2025 4:24 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025 4:24 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 424B5 | |
01/21/2025 6:52 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/10/2025 8:04 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/06/2025 4:56 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Khara Rahul (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2025 6:13 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/02/2025 3:20 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Khara Rahul (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/30/2024 3:11 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Quisel John D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/26/2024 4:18 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/23/2024 3:21 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Quisel John D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2024 6:41 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Quisel John D (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/16/2024 3:39 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Quisel John D (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/09/2024 7:48 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/26/2024 7:03 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/25/2024 3:46 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Savage William Jacob (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/19/2024 11:15 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form EFFECT | |
11/19/2024 5:46 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/15/2024 3:31 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/14/2024 4:44 PM | Bain Capital Life Sciences Opportunities III, LP (Filed by) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form SC 13G/A | |
11/14/2024 3:33 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Paradigm Biocapital Advisors LP (Filed by)
| Form SC 13G/A | |
11/08/2024 9:52 AM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G | |
Green Light for These Stocks (Ad) Guess Who Washington Will Partner With Next?
The U.S. government just made a bold $400 million move... becoming the largest shareholder in a critical mineral company tied to national security. Former hedge fund manager Whitney Tilson believes this is just the start of a sweeping plan to unlock trillions in hidden federal assets... from oil-rich land to rare earths and energy reserves. He says this could mark the beginning of the largest wealth transfer in modern U.S. history, and has identified the surprising areas where you could benefit. Click here to see how to position yourself before a looming federal deadline that's now just weeks a |
11/08/2024 7:49 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/05/2024 6:16 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/04/2024 6:55 AM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/25/2024 12:11 PM | Gemini Therapeutics (Filer) Disc Medicine, Inc. (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2024 1:02 PM | BlackRock, Inc. (Filed by) Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject)
| Form SC 13G | |
10/03/2024 3:29 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/18/2024 3:05 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) Savage William Jacob (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/16/2024 3:39 PM | Gemini Therapeutics (Subject) Disc Medicine, Inc. (Subject) Savage William Jacob (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/05/2024 3:06 PM | Gemini Therapeutics (Issuer) Disc Medicine, Inc. (Issuer) White William Richard (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |